- AU$854.89m
- AU$722.79m
- AU$203.89m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 72.09 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -21.77% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.93 | ||
| Price to Tang. Book | 3.93 | ||
| Price to Free Cashflow | 49.09 | ||
| Price to Sales | 4.19 | ||
| EV to EBITDA | 28.24 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.18% | ||
| Return on Equity | 8.35% | ||
| Operating Margin | 7.85% | ||
Financial Summary
| Year End 30th Jun | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 120.32 | 165.99 | 170.01 | 198.63 | 203.89 | 219.49 | 239.22 | 14.62% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -56.25 | +428.43 | -35.51 | +59.52 | -13.58 | -41.21 | +55.88 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon EPR. Its trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics AuditPro is an automated digital system that combines clinician infection prevention decision making, with the Trophon 2 device infection control workflow data, and patient procedure information.
Directors
- Maurie Stang NEC
- Michael Kavanagh PRE
- Steven Sargent NVC (60)
- McGregor Grant CFO
- David Morris CEX
- Ken Shaw CEX
- Ronan Wright CEX
- Rod Lopez COO
- Steven Farrugia CTO
- Renee Salaberry CMO
- Jodi Sampson EXO
- David Fisher NID
- Marie Elizabeth McDonald NID
- Lisa McIntyre NID (54)
- Geoff Wilson NID
- Last Annual
- June 30th, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- November 14th, 2000
- Public Since
- May 17th, 2007
- No. of Shareholders
- 11,578
- No. of Employees
- 508
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 298,910,874
- Address
- 7-11 Talavera Road, Macquarie Park, SYDNEY, 2113
- Web
- https://www.nanosonics.com.au
- Phone
- +61 280631600
- Auditors
- Ernst & Young
Latest News for NAN
Upcoming Events for NAN
Nanosonics Limited Annual Shareholders Meeting
Half Year 2027 Nanosonics Ltd Earnings Release
Similar to NAN
4DMedical
Australian Stock Exchange - SEATS
Adheris Health
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies Global
Australian Stock Exchange - SEATS
FAQ
As of Today at 04:15 UTC, shares in NANOSONICS are trading at AU$2.86. This share price information is delayed by 15 minutes.
Shares in NANOSONICS last closed at AU$2.86 and the price had moved by -38.36% over the past 365 days. In terms of relative price strength the NANOSONICS share price has underperformed the ASX All Ordinaries Index by -35.36% over the past year.
The overall consensus recommendation for NANOSONICS is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreNANOSONICS does not currently pay a dividend.
NANOSONICS does not currently pay a dividend.
NANOSONICS does not currently pay a dividend.
To buy shares in NANOSONICS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$2.86, shares in NANOSONICS had a market capitalisation of AU$854.89m.
Here are the trading details for NANOSONICS:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: NAN
Based on an overall assessment of its quality, value and momentum NANOSONICS is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in NANOSONICS is AU$3.88. That is 35.7% above the last closing price of AU$2.86.
Analysts covering NANOSONICS currently have a consensus Earnings Per Share (EPS) forecast of AU$0.03 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NANOSONICS. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -17.1%.
As of the last closing price of AU$2.86, shares in NANOSONICS were trading -15.15% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NANOSONICS PE ratio based on its reported earnings over the past 12 months is 72.09. The shares last closed at AU$2.86.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NANOSONICS' management team is headed by:
- Maurie Stang - NEC
- Michael Kavanagh - PRE
- Steven Sargent - NVC
- McGregor Grant - CFO
- David Morris - CEX
- Ken Shaw - CEX
- Ronan Wright - CEX
- Rod Lopez - COO
- Steven Farrugia - CTO
- Renee Salaberry - CMO
- Jodi Sampson - EXO
- David Fisher - NID
- Marie Elizabeth McDonald - NID
- Lisa McIntyre - NID
- Geoff Wilson - NID